Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 29, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Ondansetron, and when can generics launch?

Ondansetron is a drug marketed by Sun Pharm Inds Ltd, Chartwell Molecules, Teva, Nesher Pharms, Mylan, Sandoz, Glenmark Generics, Sun Pharm Inds, Aurobindo Pharma, Barr, Apotex, Taro, Qilu Pharm Co Ltd, Pliva Hrvatska Doo, Lannett, Emcure Pharms, Gland Pharma Ltd, Sandoz Inc, Luitpold, Hospira, Silarx, Hikma Intl Pharms, Accord Hlthcare, Sun Pharm Inds (in), Natco Pharma Ltd, Mylan Labs Ltd, West-ward Pharms Int, Ipca Labs Ltd, Apotex Inc, Fresenius Kabi Usa, Wockhardt, Sagent Pharms, Hikma Farmaceutica, Amneal Pharms, Dr Reddys Labs Ltd, Claris, Aurobindo Pharma Ltd, Taro Pharms Ireland, and Emcure Pharms Ltd. and is included in seventy-eight NDAs.

The generic ingredient in ONDANSETRON is ondansetron hydrochloride. There are twenty-eight drug master file entries for this compound. Seventy-one suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the ondansetron hydrochloride profile page.

Summary for Tradename: ONDANSETRON

Suppliers / Packagers: see list34
Bulk Api Vendors: see list77
Clinical Trials: see list146
Patent Applications: see list5,001
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ONDANSETRON at DailyMed

Pharmacology for Tradename: ONDANSETRON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ipca Labs Ltd
ondansetron hydrochloride
TABLET;ORAL203761-002Jan 23, 2014ABRXNoNo► Subscribe► Subscribe
Apotex Inc
ondansetron hydrochloride
INJECTABLE;INJECTION077343-001Dec 26, 2006DISCNNoNo► Subscribe► Subscribe
ondansetron hydrochloride
TABLET;ORAL077729-002Mar 28, 2011DISCNNoNo► Subscribe► Subscribe
Pliva Hrvatska Doo
ondansetron hydrochloride
TABLET;ORAL077112-003Jun 25, 2007ABRXNoNo► Subscribe► Subscribe
Amneal Pharms
ondansetron hydrochloride
SOLUTION;ORAL091483-001Jan 31, 2011AARXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus